downsides of tirzepatide vs. Semaglutide: Key Differences & Benefits Tirzepatide: A Promising Medication for

Additionally, several GLP-1 receptor agonists are being developed or repurposed for the treatment of alcohol, tobacco, and opioid use disorders

Victoza lowered the risk of death from heart and blood vessel diseases by 22% in the LEADER clinical trial

While compounded semaglutide hasnt been FDA-approved, compounded drugs from state-licensed pharmacies that stick to the FDAs Current Good Manufacturing Practice (CGMP) guidelines are considered safe

GLP-1 medications are associated with a small increased risk of diabetic retinopathy progression in patients with pre-existing eye disease, particularly during rapid blood glucose improvement